Case 61 had an NRASG12C mutation in the invasive portion and a metastasis, whereas the melanoma in situ instead had separate amplifications involving KIT and CRKL, both being known driver mutations of acral melanoma28,29. The gene discussed is CRKL; the disease is melanoma.